Category Archives: Pharma & Biotech

Pharma & Biotech Press Releases & News distributed via EuropaWire

FluMist Becomes First At-Home Self-Administered Flu Vaccine Approved by FDA

Posted on 21, September 2024 by

(IN BRIEF) FluMist, a needle-free nasal spray influenza vaccine, has been approved by the FDA for self-administration in the US, making it the first flu vaccine of its kind to be used at home. Adults up to 49 years old … Read the full press release →

Posted in Business, Financial, Healthcare, Industrial, Investment, Management, News, Pharma & Biotech, Science, Security & Safety, Technology, United Kingdom

Tagged , , , , , , , , ,

Basilea Secures USD 268 Million Agreement with BARDA to Develop Novel Antifungal and Antibacterial Treatments

Posted on 19, September 2024 by

(IN BRIEF) Basilea Pharmaceutica has entered into a multi-year agreement with the Biomedical Advanced Research and Development Authority (BARDA) to support the development of novel antifungal and antibacterial treatments. The agreement provides an initial USD 29 million, with the potential … Read the full press release →

Posted in Business, Financial, Government, Healthcare, Industrial, Investment, News, Pharma & Biotech, Science, Security & Safety, Switzerland, Technology

Tagged , , , , , , , , ,

FDA Approves AstraZeneca’s Fasenra for Eosinophilic Granulomatosis with Polyangiitis, Offering New Hope for Patients

Posted on 18, September 2024 by

(IN BRIEF) AstraZeneca’s Fasenra (benralizumab) has been approved by the US FDA for the treatment of eosinophilic granulomatosis with polyangiitis (EGPA), a rare immune-mediated vasculitis that can be fatal without treatment. The approval is based on results from the MANDARA … Read the full press release →

Posted in Business, Financial, Government, Healthcare, Industrial, Investment, Management, Marketing, News, Pharma & Biotech, Science, Security & Safety, Technology, United Kingdom

Tagged , , , , , , , , ,

International Consortium Invests €35 Million in Abolis Biotechnologies for Sustainable Growth

Posted on 13, September 2024 by

(IN BRIEF) Abolis Biotechnologies has secured €35 million from a global consortium of investors, including Evonik Venture Capital, BOLD (L’Oréal’s fund), and the DeepTech & Climate Fonds. This investment will help the company expand its biomanufacturing capabilities and bring sustainable, … Read the full press release →

Posted in Business, Chemicals, Environment, Financial, France, Germany, Government, Industrial, Investment, Management, Netherlands, News, Pharma & Biotech, Science, Technology

Tagged , , , , , , , , , ,

GSK’s mRNA Flu Vaccine Candidate Moves to Phase III After Positive Phase II Results

Posted on 12, September 2024 by

(IN BRIEF) GSK has reported positive results from its phase II trial for an mRNA seasonal influenza vaccine candidate, showing strong immune responses against influenza A and B strains in both younger and older adults. The trial met success criteria … Read the full press release →

Posted in Business, Financial, Industrial, Investment, Management, News, Pharma & Biotech, Science, Security & Safety, Technology, United Kingdom

Tagged , , , , , ,

GSK’s Depemokimab Cuts Severe Asthma Attacks by Over 50% in Phase III Trials

Posted on 10, September 2024 by

(IN BRIEF) GSK’s depemokimab, a new ultra-long-acting biologic, showed a 54% reduction in severe asthma exacerbations in the SWIFT-1 and SWIFT-2 phase III trials. Administered every six months, it also demonstrated a 72% reduction in hospitalizations and emergency visits, offering … Read the full press release →

Posted in Business, Financial, Healthcare, Industrial, Investment, Management, News, Pharma & Biotech, Science, Security & Safety, Technology, United Kingdom

Tagged , , , , , , ,

AstraZeneca Pioneers Low-Impact Inhalers with Eco-Friendly Breztri Transition

Posted on 9, September 2024 by

(IN BRIEF) AstraZeneca has completed clinical studies to transition Breztri, its inhaled treatment for COPD, to a next-generation propellant with 99.9% lower Global Warming Potential. This change aligns with AstraZeneca’s commitment to reducing its environmental impact through its Ambition Zero … Read the full press release →

Posted in Business, Environment, Financial, Healthcare, Industrial, Investment, Management, Marketing, News, Pharma & Biotech, Science, Security & Safety, Technology, United Kingdom

Tagged , , , , , , , ,

Krka Commemorates 70 Years of Innovation with a New Chapter in Sculpture

Posted on 6, September 2024 by

(IN BRIEF) Krka celebrated its 70th anniversary by unveiling a new book with an inscription alongside its “Girl with the Growing Book” sculpture. The new book’s inscription reflects the company’s commitment to ambitious ideas, professionalism, creativity, and courage. Slovenian President … Read the full press release →

Posted in Business, Financial, Industrial, Investment, Management, Media, News, Pharma & Biotech, Science, Slovenia, Technology

Tagged , , , , , ,

Advancements in Vision Preservation: Boehringer Ingelheim’s Breakthrough in Geographic Atrophy Treatment

Posted on 6, September 2024 by

(IN BRIEF) Boehringer Ingelheim and CDR-Life have reported positive results from the Phase I trial of BI 771716, an investigational treatment for geographic atrophy (GA), a severe form of age-related macular degeneration. The antibody fragment met its primary safety endpoints, … Read the full press release →

Posted in Business, Financial, Germany, Healthcare, Industrial, Investment, Management, News, Pharma & Biotech, Science, Technology

Tagged , , , , ,

Basilea Pharmaceutica Reaches Milestone with Strong European Sales of Cresemba®

Posted on 6, September 2024 by

(IN BRIEF) Basilea Pharmaceutica Ltd announced that its antifungal drug, Cresemba® (isavuconazole), achieved significant sales in Europe, triggering a USD 25 million milestone payment from partner Pfizer. This achievement highlights Cresemba’s strong performance in treating severe fungal infections. The milestone … Read the full press release →

Posted in Business, Financial, Healthcare, Industrial, Investment, Management, News, Pharma & Biotech, Science, Switzerland, Technology

Tagged , , , , ,

GSK to Showcase Transformative Respiratory Research at ERS Congress 2024

Posted on 3, September 2024 by

(IN BRIEF) GSK will present significant research at the 2024 European Respiratory Society (ERS) Congress, including data from phase III trials of its new biologic, depemokimab, for severe asthma. The presentations highlight GSK’s commitment to advancing respiratory medicine, with a … Read the full press release →

Posted in Business, Financial, Healthcare, Industrial, Investment, Management, Media, News, Pharma & Biotech, Science, Technology, United Kingdom

Tagged , , ,

AstraZeneca to Present Key Cancer Research Breakthroughs at WCLC and ESMO 2024

Posted on 3, September 2024 by

(IN BRIEF) AstraZeneca will present significant cancer research at the 2024 World Conference on Lung Cancer (WCLC) and the European Society for Medical Oncology (ESMO) Congress. Highlights include new data on the effectiveness of Imfinzi in bladder cancer, a novel … Read the full press release →

Posted in Business, Financial, Healthcare, Industrial, Investment, Management, Marketing, Media, News, Pharma & Biotech, Science, Technology, United Kingdom

Tagged , , , , ,

Sanofi’s Tolebrutinib Shows Breakthrough Potential in Slowing Disability Progression for Multiple Sclerosis Patients

Posted on 2, September 2024 by

(IN BRIEF) Sanofi’s phase 3 study for its drug tolebrutinib has shown promising results in treating non-relapsing secondary progressive multiple sclerosis (nrSPMS), a condition with no current approved therapies. The HERCULES study revealed that tolebrutinib successfully delayed disability progression in … Read the full press release →

Posted in France, Healthcare, Pharma & Biotech

Tagged , , , , , , , , , , , , , , , , , , , , ,

Roche’s PiaSky Approved in EU as First Monthly Self-Administered Treatment for PNH

Posted on 28, August 2024 by

(IN BRIEF) Roche has received approval from the European Commission for PiaSky® (crovalimab), a novel treatment for paroxysmal nocturnal haemoglobinuria (PNH), making it the first monthly subcutaneous (SC) treatment available in the European Union. PiaSky, which can be self-administered by … Read the full press release →

Posted in Business, Financial, Healthcare, Industrial, Investment, Management, News, Pharma & Biotech, Science, Security & Safety, Switzerland, Technology

Tagged , , , ,

Brenntag Strengthens Presence in Brazilian Life Science Market with Acquisition of PIC and PharmaSpecial

Posted on 20, August 2024 by

(IN BRIEF) Brenntag has expanded its presence in Brazil’s Life Science market with the acquisition of specialty chemicals distributors PIC and PharmaSpecial. The deal, which adds an Applications & Innovation Center and two laboratories to Brenntag’s network, will enhance its … Read the full press release →

Posted in Business, Chemicals, Environment, Financial, Germany, Government, Industrial, Infrastructure & Utilities, Investment, Management, News, Pharma & Biotech, Science, Switzerland, Technology

Tagged , , , , , , , , , ,

SISTO Armaturen S.A. Introduces Automated Multi-Port Valve to Revolutionize Pharmaceutical Production

Posted on 14, August 2024 by

(IN BRIEF) SISTO Armaturen S.A., part of the KSB Group, has developed the SISTO-CM1300, an automated multi-port valve designed to optimize pharmaceutical production processes. This valve automates the switching of fluids in cleaning and sterilization processes, reducing the risk of … Read the full press release →

Posted in Business, Environment, Financial, Germany, Government, Healthcare, Industrial, Infrastructure & Utilities, Investment, Luxembourg, Management, News, Pharma & Biotech, Technology

Tagged , , , , , ,

Eckert & Ziegler and Telix Partner to Support Phase III Prostate Cancer Study with Advanced Radiopharmaceutical Manufacturing

Posted on 14, August 2024 by

(IN BRIEF) Eckert & Ziegler has signed a multi-year agreement with Telix Pharmaceuticals to serve as the European contract manufacturing organization for Telix’s ProstACT GLOBAL Phase III study. The agreement includes supplying patients from Eckert & Ziegler’s Berlin facility and … Read the full press release →

Posted in Business, Environment, Financial, Germany, Government, Healthcare, Industrial, Investment, Management, News, Pharma & Biotech, Science, Technology

Evotec and Bristol Myers Squibb Strengthen Molecular Glue Partnership with $75 Million Milestone Payments

Posted on 14, August 2024 by

(IN BRIEF) Evotec SE has made significant progress in its strategic partnership with Bristol Myers Squibb, focused on developing a molecular glue-based therapy pipeline. This success has led to $75 million in milestone payments to Evotec. The partnership, which began … Read the full press release →

Posted in Business, Environment, Financial, Germany, Government, Healthcare, Industrial, Investment, Management, News, Pharma & Biotech, Science, Technology

Tagged , , , , , ,

Enhertu Gains Conditional Approval in China for Advanced HER2-Positive Gastric Cancer Treatment

Posted on 13, August 2024 by

(IN BRIEF) AstraZeneca and Daiichi Sankyo’s Enhertu has received conditional approval in China for treating locally advanced or metastatic HER2-positive gastric cancer, following promising results from the DESTINY-Gastric06 trial. This marks the third approval for Enhertu in China in less … Read the full press release →

Posted in Business, Environment, Financial, Government, Healthcare, Industrial, Investment, Management, News, Pharma & Biotech, Science, Security & Safety, Technology, United Kingdom

Tagged , , , , , , , , , , ,

New Technique Promises to Improve Drug Delivery and Reduce Injections for Cancer and HIV Patients

Posted on 9, August 2024 by

(IN BRIEF) Professor Remco Tuinier and his team at Eindhoven University of Technology have developed a new method to slow the release of protein-based drugs, addressing the challenge of rapid dispersion in the body. By using polyethylene glycol (PEG) and … Read the full press release →

Posted in Business, Education, Financial, Healthcare, Industrial, Investment, Management, Netherlands, News, Pharma & Biotech, Science, Technology

Tagged , , , , ,